PBMs have responded to gene therapies through a combination of prior authorization requirements (which serve as the primary utilization management tool), outcomes-based payment arrangements with manufacturers, and in some cases, carve-out arrangements where gene therapy coverage is managed separately from the standard pharmacy benefit
The daily recommendation is 4 tablets, so if youre someone who barely downs one vitamin a day, this may not be a great fit
I have nothing but good things to say about them
10.1016/j.cellsig.2017.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar] Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S et al (2014) Beneficial effects of caffeine in a transgenic model of Alzheimers disease-like tau pathology
Acute kidney disease and acute kidney injury biomarkers in coronary care unit patients